{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:22Z","timestamp":1790999722153,"version":"4.1.0"},"reference-count":10,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","funder":[{"DOI":"10.13039\/100007683","name":"Nihon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1297\/cpe.2026-0051","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:10:24Z","timestamp":1784153424000},"page":"379-383","source":"Crossref","is-referenced-by-count":0,"title":["Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia"],"prefix":"10.1297","volume":"35","author":[{"given":"Masako","family":"Aoki","sequence":"first","affiliation":[{"name":"Nihon University Itabashi Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Nagano","sequence":"additional","affiliation":[{"name":"Nihon University Itabashi Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Aoki","sequence":"additional","affiliation":[{"name":"Nihon University Itabashi Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sumi","sequence":"additional","affiliation":[{"name":"Nihon University Itabashi Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[{"name":"Nihon University Itabashi Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Savarirayan, R, Hoover-Fong, J, Ozono, K, Backeljauw, P, Cormier-Daire, V, DeAndrade, K, et al. International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia. Nat Rev Endocrinol 2025;21: 314\u201324.","DOI":"10.1038\/s41574-024-01074-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Savarirayan, R, Wilcox, WR, Harmatz, P, Phillips, J, Polgreen, LE, Tofts, L, et al. Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Child Adolesc Health 2024;8: 40\u201350.","DOI":"10.1016\/S2352-4642(23)00265-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tofts, L, Ireland, P, Tate, T, Raj, S, Carroll, T, Munns, CF, et al. Consensus guidelines for the use of vosoritide in children with achondroplasia in Australia. Children (Basel) 2024;11: 11.","DOI":"10.3390\/children11070789"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vu, GH, Xu, W, Go, BC, Humphries, LS, Kalmar, CL, Taylor, JA, et al. Physiologic timeline of cranial-base suture and synchondrosis closure. Plast Reconstr Surg 2021;148: 973e\u201382e.","DOI":"10.1097\/PRS.0000000000008570"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hallett, SA, Ono, W, Franceschi, RT, Ono, N. Cranial base synchondrosis: chondrocytes at the hub. Int J Mol Sci 2022;23: 23.","DOI":"10.3390\/ijms23147817"},{"key":"6","first-page":"e10568","volume":"6","year":"2021","unstructured":"6. Rignol, G, Garcia, S, Authier, F, Smith, K, Tosello, L, Marsault, R, et al. Longitudinal imaging of the skull base synchondroses demonstrates prevention of premature ossification after recifercept treatment in a mouse model of achondroplasia. JBMR Plus 2021;6: e10568.","journal-title":"JBMR Plus","ISSN":"https:\/\/id.crossref.org\/issn\/2473-4039","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cheung, MS, Irving, M, Cocca, A, Santos, R, Shaunak, M, Dougherty, H, et al. Achondroplasia Foramen Magnum Score: screening infants for stenosis. Arch Dis Child 2021;106: 180\u20134.","DOI":"10.1136\/archdischild-2020-319625"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ando, R, Numata, O. Foramen Magnum Stenosis in Achondroplasia: Imaging-Based Surgical Indications, Synchondrosis Fusion, and the Role of Ventriculomegaly. Pediatr Neurosurg 2026; Feb 21: 1\u201314.","DOI":"10.1159\/000551092"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Reincke, S, Semler, O, Jungh\u00e4nel-Welzing, S, Stasek, S, Rehberg, M, Pfeiffer, E, et al. Real-world outcome of vosoritide treatment in children with achondroplasia: a 12-month retrospective observational study. J Endocr Soc 2025;9: bvaf041.","DOI":"10.1210\/jendso\/bvaf041"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sawamura, K, Kitoh, H, Kamiya, Y, Mishima, K, Matsushita, M, Imagama, S. Changes in the alignment of the spine and lower limb in children with achondroplasia treated with vosoritide: a single-center, 1-year follow-up prospective study. J Pediatr Orthop 2025;45: 519\u201324.","DOI":"10.1097\/BPO.0000000000002980"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/35\/4\/35_2026-0051\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:40:38Z","timestamp":1790998838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/35\/4\/35_2026-0051\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2026-0051","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026-0051"}}